Excellent reporting @FT on #Pfizer. It is as wrong to demonise as it is to lionise the company, set for revenue of USD 80bn (!) this year. No private co. sd be able to dictate to governments as Pfizer has.
Oddly the article doesn't mention patent waivers.
1/3
Oddly the article doesn't mention patent waivers.
1/3
https://twitter.com/khalafroula/status/1465584264213377026
I'm sceptical that a patent waiver will quickly resolve shortages in low-income countries, & concerns about longer-run negative effects are serious. But it is the lever to ensure the pharma co.s behave responsibly. e.g. 1:1 #COVAX donation for hi-income-country sales.
2/3
2/3
An absolute minimum is that the vax companies have to be more transparent about their order books and sales policies.
There is also the separate but related issue of how and where the revenue streams and profits are taxed.
3/3
There is also the separate but related issue of how and where the revenue streams and profits are taxed.
3/3
PS If you find yourself on the wrong side of a paywall, try registering with the FT for limited access:
https://twitter.com/RKWinvisibleman/status/1465631001619664906?s=20
• • •
Missing some Tweet in this thread? You can try to
force a refresh
